Nanovex Biotechnologies provides plain polymeric biodegradable nanoparticles and nanocapsules based on poly(lactide-co-glycolide) (PLGA) acid terminated with different lactide/glycolide ratio and molecular weights depending on the application. Our systems can be used as drug delivery carriers by means of the incorporation of hydrophobic molecules in the matrix of our PLGA nanoparticles or hydrophilic molecules that can be entrapped into the hydrophilic pockets of our PLGA nanocapsules.
Our PLGA nanoparticles and nanocapsules are ideal to test the compatibility of these carriers in your system, before including any active pharmaceutical ingredient into the nano-scale drug carriers.
In addition, our customers can use our PLGA nanospheres without the need of the encapsulation process since our carriers possess carboxylic groups in their surface that allows the permanent attachment of their therapeutic molecules by the carbodiimide chemistry (service also provided by Nanovex Biotechnologies).
Moreover, Nanovex Biotechnologies offers custom encapsulation service to incorporate both hydrophobic and hydrophilic molecules, like cancer drugs, proteins, peptides or enzymes, in our PLGA nanospheres. (Click here to get more information about our custom encapsulation service)